Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained IOP Elevation or Ocular Hypotensive Treatment

IMPORTANCE: For the management of retinal disease, use of intravitreous injections of anti-vascular endothelial growth factor has increased. Recent reports have suggested that this therapy may cause persistent intraocular pressure (IOP) elevation and potentially increase the risk of glaucoma in pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Ophthalmol
Main Authors: Bressler, Susan B., Almukhtar, Talat, Bhorade, Anjali, Bressler, Neil M., Glassman, Adam R., Huang, Suber S., Jampol, Lee M., Kim, Judy E., Melia, Michele
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496789/
https://ncbi.nlm.nih.gov/pubmed/25719991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2015.186
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados